+44 (0) 753 598 8369 [email protected]

Attending ISPOR 2024, Atlanta? Catch up with us at our podium presentations or just drop by our booth #1024 to pick up some Kindness goodies. See you soon!

Kindness is Cost-effective


Advancing healthcare by connecting data and research to evidence-based decision making

Our multi-disciplinary experts strive to achieve a fine balance of academic quality and industry professionalism.
We provide efficient and innovative HEOR and RWE services tailored to your needs.


Health Economic Modelling

Cutting-edge methods to ensure scientifically robust and user-friendly models


RWE & Data Analytics

Analysis of Real World Data to study disease epidemiology and its impact in each phase of product lifecycle


Review & Evidence Synthesis

Assessment of different studies within the scope of existing knowledge for a specific objective


Market access and Value communication

Effectively communicating the clinical and economic value of healthcare technologies to payers and reimbursement agencies


HEOR Training

In a small group or personalized one on one session learn HEOR concepts from basic to advanced from the best in industry experts


Patient-Centric Research

Active and effective involvement of patients throughout the research (start to end and beyond) for holistic and shared healthcare decision-making. ​

We understand your Needs

This is why we focus on maintaining a perfect balance across the three dimensions of academic and professional efficiency.

Timeliness, Quality assurance and Value for money.

Latest Blog

The “Proportionate Approach Route” for Technology Appraisal by NICE 
The “Proportionate Approach Route” for Technology Appraisal by NICE 

The innovation of the new treatments has outpaced the rate at which NICE (The National Institute for Health and Care Excellence) appraises the treatments via its existing method of appraisal. NICE recently announcing taking a “proportionate approach” to technology appraisals is a landscape change ensuring faster guidance and efficiency gains.

Real World Evidence: From Vision to Reality
Real World Evidence: From Vision to Reality

Framework of Developing Real world Evidence (RWE) There has been a burgeoning bid about the use of Real-World data in healthcare. The National Institute for Health and Care Excellence (NICE) has released the NICE real-world evidence framework on 23rd June 2022 which...

Latest Publications

Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia

Saiyed M, Byrnes J, Srivastava T, Scuffham P, Downes M

Nov 2020

In the REFLECT trial, lenvatinib showed superior clinical benefits to sorafenib in terms of progression-free survival and was non-inferior for overall survival in the treatment of advanced hepatocellular carcinoma (HCC). The study assessed the cost-effectiveness of lenvatinib compared with sorafenib for patients with advanced HCC in Australia.

Discrete Time Markov Models

Improving Cycle Corrections in Discrete Time Markov Models: A Gaussian Quadrature Approach [Pre Print]

Srivastava T, Strong M, Stevenson MD, Dodd P

Nov 2019

In this study, a novel cycle correction method based on Gaussian Quadrature (GQ) is introduced for Markov Models. A simulation study was conducted to compare the GQ method with existing methods. Fifth order GQ method outperformed other existing methods in 99.8% scenarios.

Volume–Outcome Relationships in Open and Endovascular Repair of Abdominal Aortic Aneurysm: Administrative Data 2006–2018

Tong T, Aber A, Chilcott J, Thokala P et al

Aug 2020

The aim of this study was to analyse real-world hospital-based patient level data (70k+ patients) to investigate and update volume–outcome relationships after open surgical repair (OSR) and endovascular repair (EVAR) of abdominal aortic aneurysm in England.


Partner with ConnectHEOR

2 + 12 =